![REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube](https://i.ytimg.com/vi/HT9SQRDXsto/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLD-jxJZtZmbO9EAtPrp6ZFjtLvjGQ)
REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube
![REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube](https://i.ytimg.com/vi/NqnJgJpVDug/sddefault.jpg)
REPLICEL RCH-01 HAIR LOSS TREATMENT **TERMINATES** LICENSE AGREEMENT WITH SHISEIDO. F&*K!! - YouTube
RepliCel Life Sciences Inc. - We're expecting data from the Japanese clinical research from Shiseido later this year. In the meantime, visit our website to learn more about hair regeneration: http://bit.ly/2n6vFBt
![Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date](https://www.sec.gov/Archives/edgar/data/1205059/000127956917000691/image_002.jpg)
Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date
![Local hair-loss biotech RepliCel completes $4.2m deal with cosmetics giant - Technology | Business in Vancouver Local hair-loss biotech RepliCel completes $4.2m deal with cosmetics giant - Technology | Business in Vancouver](https://biv.com/sites/default/files/styles/media_image/public/2017-12/gv_20130715_biv0112_130719968.jpg?itok=vmy9Sjgm)